Pheast gets FDA Fast Track for PHST001 in Ovarian Cancer
03 Jun 2025 //
BUSINESSWIRE
Pheast Therapeutics Treats First Patient in PHST001 Phase 1 Trial
14 Apr 2025 //
BUSINESSWIRE
Pheast Appoints Dr. Raphaël Rousseau as Chief Medical Officer
18 Feb 2025 //
BUSINESSWIRE
Pheast`s Preclinical Data on PHST001 Macrophage Inhibitor at SITC
07 Nov 2024 //
BUSINESSWIRE

Market Place
Sourcing Support